MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET
Company Participants
Matt Notarianni - Head, Investor Relations
Joe Capper - Chief Executive Officer
Doug Rice - Chief Financial Officer
Conference Call Participants
Ross Osborn - Cantor Fitzgerald
Chase Knickerbocker - Craig-Hallum Capital Group
Brooks O'Neil - Lake Street Capital Markets
Anthony Petrone - Mizuho Group
Carl Byrnes - Northland Capital Markets
Operator
Greetings and welcome to the MiMedx Second Quarter 2024 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Matt Notarianni, Head of Investor Relations. Thank you, sir. You may begin.
Matt Notarianni
Thank you, operator, and good afternoon everyone. Welcome to the MiMedx second quarter 2024 operating and financial results conference call. With me on today's call are Chief Executive Officer, Joe Capper; and Chief Financial Officer, Doug Rice. As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at mimedx.com.
Joe will kick us off with some opening remarks and a summary of our operating highlights and Doug will provide a review of our financial results for the quarter. And then Joe will conclude with some additional updates including a discussion of our financial goals. We will then be available for your questions.
Before we begin, I would like to remind you that our comments today will include forward-looking statements including statements regarding future sales, adjusted EBITDA, free cash flow and cash balance growth, future margins and expenses and expected market sizes for our products. These expectations are subject to risks and uncertainties and actual results may differ materially from those anticipated due to many factors.
Actual results and market sizes will depend on a number of factors including competition, access to customers, the reimbursement environment, unforeseen circumstances and delays and other factors. Additional factors that could impact outcomes and our results include those described in the Risk Factors section of our annual report on Form 10-K and our quarterly reports on Form 10-Q.
Also our comments today include non-GAAP financial measures and we provide a reconciliation to GAAP measures in our press release, which is available on our website at mimedx.com.